Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Breast Neoplasms 18Prostatic Neoplasms 8Osteoporosis 8Vitamin D Deficiency 4Polycystic Ovary Syndrome 4Colonic Neoplasms 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Neoplasms 3Colorectal Neoplasms 3Bone Diseases, Metabolic 3Obesity 2Neoplasm Metastasis 2Multiple Endocrine Neoplasia Type 1 2Lymphoma 2Lung Neoplasms 2Leukemia 2Inflammation 2Cardiovascular Diseases 2Carcinoma, Transitional Cell 2Brain Neoplasms 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Ureteral Neoplasms 1Thyroid Neoplasms 1Solid Cancers 1Sexual Dysfunction, Physiological 1Rectal Neoplasms 1Psoriasis 1Pancreatic Neoplasms 1

Interventions

pembrolizumab 25Gemcitabine 21Nivolumab 17Cisplatin 17atezolizumab 14Carboplatin 11avelumab 9vinflunine 7Ipilimumab 7Paclitaxel 6Docetaxel 5enfortumab vedotin 4cabazitaxel 4Pemetrexed 4Mitomycin 4cabozantinib 3Taxes 3Rogaratinib 3Magnetic Resonance Spectroscopy 3Injections 3Albumin-Bound Paclitaxel 3tremelimumab 2sacituzumab govitecan 2pemigatinib 2niraparib 2lenvatinib 2bempegaldesleukin 2apatorsen 2XRP6258 2Vitamin D 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Carcinoma, Transitional Cell × Vitamin D × Clear all
NCT04197089 2022-08-03

VitDURO

Germans Trias i Pujol Hospital

Phase 4 Completed
2 enrolled
Genitourinary

Carcinoma, Transitional Cell, Neoplasms

NCT03520231 2021-11-23

Study Comparing Denosumab With Standard Treatment in Urothelial Cancer Patients With Bone Metastases

University Health Network, Toronto

Phase 2 Completed
6 enrolled
Genitourinary

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Kidney Neoplasms, Ureteral Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡